1262482-52-9

Basic information

• Product Name: (3aS,4S,7aR)-hexahydro-2H-furo[2,3-b]pyran-4-yl-(2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl carbamate
• Synonyms: (3aS,4S,7aR)-hexahydro-2H-furo[2,3-b]pyran-4-yl-(2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl carbamate
• CAS NO: 1262482-52-9
• Molecular Weight: 561.7
• Mol File: 1262482-52-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (3aS,4S,7aR)-hexahydro-2H-furo[2,3-b]pyran-4-yl-(2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: (3aS,4S,7aR)-hexahydro-2H-furo[2,3-b]pyran-4-yl-(2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl carbamate(1262482-52-9)
• EPA Substance Registry System: (3aS,4S,7aR)-hexahydro-2H-furo[2,3-b]pyran-4-yl-(2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl carbamate(1262482-52-9)

Safety Data

• Hazardous Substances Data: 1262482-52-9(Hazardous Substances Data)

Upstream product

• 54442-06-7 2R-(2-acetoxyethyl)-3-cyclopenten-1S-ol 
• 1075209-44-7 (1S,2R)-2-[1-(tert-butyldimethylsilyloxy)cyclopent-3-en-2-yl]ethyl acetate 
• 1075209-47-0 (3aS,4S,7aR)-hexahydro-4H-furo[2,3-b]pyran-4-yl (4-nitrophenyl) carbonate 
• 169280-56-2 4-amino-N-(2R,3S)(3-amino-2-hydroxy-4-phenylbutyl)-N-isobutylbenzenesulfonamide 
• 1075209-45-8 C₁₃H₂₆O₂Si 
• 1262482-21-2 (4S,4aS,7aR)-4-(tert-butyldimethylsilyloxy)hexahydrofuro-[2,3-b]pyrane 
• 1075209-46-9 (3aS,4S,7aR)-hexahydro-2H-furo[2,3-b]pyran-4-ol 
• 26054-46-6 (-)-(1S,5R)-2-oxabicyclo[3.3.0]oct-6-en-3-one 
• 49826-08-6 (1S,2R)-2-(2'-hydroxyethyl)-3-cyclopenten-1-ol 
• 98516-10-0 acetic acid (1R,6S)-6-hydroxymethyl-cyclohex-3-enylmethyl ester 
• 954148-36-8 (1R,2S)-[2-[(acetyloxy)methyl]cyclohex-4-en-1-yl]methyl acetate 

Relevant articles and documents

An enantioselective enzymatic desymmetrization route to hexahydro-4H-furopyranol, a high-affinity ligand for HIV-1 protease inhibitors

An enantioselective synthesis of (3aS,4S,7aR)-hexahydro-4H-furo[2,3-b]pyran-4-ol, a high-affinity nonpeptide ligand for a variety of potent HIV-1 protease inhibitors is described. The key steps involved a highly enantioselective enzymatic desymmetrization